Find clinical trials in your area

Search by disease and location to discover available clinical trials matching your criteria.

Matched clinical trials

  • Long-term safety study of eptinezumab given by intravenous infusion for children and adolescents aged 6-17 years with chronic or episodic migraine

    Recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    Italy Poland Portugal Spain
  • Long-Term Safety and Efficacy Study of Mexiletine Hydrochloride for Patients with Myotonic Dystrophy Type 1 and Type 2

    Recruiting

    3 1 1
    Investigated drugs:
    Belgium Denmark Germany Italy Spain
  • Study on the Effects of Mexiletine for Treating Myotonic Dystrophy Types 1 and 2 in Patients

    Recruiting

    3 1
    Investigated diseases:
    Investigated drugs:
    Belgium Denmark Germany Italy Spain
  • A study to evaluate the effectiveness of a drug combination in reducing respiratory tract infections in children aged 3 to 12 years.

    Recruiting

    3 1 1
    Poland
  • A study to evaluate the safety and effectiveness of filgotinib in children and adolescents aged 8 to 17 years with polyarticular juvenile idiopathic arthritis

    Recruiting

    3 1 1 1
    Investigated drugs:
    Belgium Bulgaria Czechia France Germany Greece +4
  • A study to evaluate the effectiveness and safety of zasocitinib in children and adolescents with moderate-to-severe plaque psoriasis

    Recruiting

    3 1
    Investigated drugs:
    Germany Italy Poland Spain
  • A study to evaluate the safety and effectiveness of filgotinib in children and adolescents with juvenile idiopathic arthritis.

    Recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    France Germany
  • A study to evaluate the effects of BI 764198 in adults and adolescents with focal segmental glomerulosclerosis (FSGS)

    Recruiting

    3 1
    Investigated diseases:
    Belgium Croatia Denmark France Germany Greece +9
  • Study of the use of tasadenoturev for children and young adults with recurrent or resistant high-grade brain tumors

    Recruiting

    2 1 1
    Investigated diseases:
    The Netherlands Spain
  • A Phase 3 study to evaluate the efficacy and safety of ION582 in children and adults with Angelman syndrome

    Recruiting

    3 1 1
    Germany Italy Poland Spain